Publications by authors named "Shusha Yin"

Claim this Profile
W
WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.
Hongbiao Huang, Yujie Xiang, Yuanfei Deng, Qing Liu, Gengxi Cai, Shusha Yin, E-Ying Peng

Oncogene· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer.
Hongbiao Huang, Xuefen Zhuang, Shusha Yin, Wenshuang Sun, Ji Cheng, E-Ying Peng

Oncogene· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
METTL14-mediated mA modification enhances USP22-ERα axis to drive breast cancer malignancy.
Xuefen Zhuang, Shusha Yin, Ji Cheng, Wenshuang Sun, Zesen Fang, E-Ying Peng

Pharmacol Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration.
Zhenlong Shao, Shutong Liu, Wenshuang Sun, Xuefen Zhuang, Shusha Yin

Cell Mol Biol Lett· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma.
Yuning Liao, Yuan Liu, Cuifu Yu, Qiucheng Lei, Ji Cheng, Shusha Yin

Adv Sci (Weinh)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis